3[4]Prince M J, Harwood R H, Thomas A, et al. A Prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression. The Gospel ()ak Project Ⅶ [J]. Cambridge University Press, 1998,28(2): 337.
5[8]Blanchard M R, Waterreus A, Mann A H. The Effect o f primary care nurse intervention upon older peoplescreened as depressed [ J]. International Journal of Geriatric Psychiatry, 1995, 10: 98.
6[9]Banerjee S, Shamash K, Macdonald AJD, et al. Randomized controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home[J]. British Medical Journal, 1996, 313(7064): 1058.
7[10]Unutzer J, Katon W, Callahan C M, et al. Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial[J]. Journal of the American Medical Association,2002, 288(22): 2836.
8[12]Unutzer J, Katon W, Williams J W, et al. Improving primary care for depression in late life: the design of a multicenter randomized trial[J]. med care. 2001, 39(8) :785.
6Katz RJ, Roth KA, Carroll BJ. Acute and chronic stress effects on open field activity in the rat.. implications for a model of depression[J]. Neurosci Biobehav Rev, 1981,5 (2) :247-251.
7Fernandez F, Misilmeri MA, Felger JC, et al. Nociceptin/ orphanin FQ increases anxiety-related behavior and circu- lating levels of corticosterone during neophobic tests ofanxiety[J].Neuropsychopharmacology, 2004,29 ( 1 ) : 59- 71.
8Marti M, Stoeehi S, Paganini F, et al. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline re- lease in the rat neocortex[J]. Br J Pharmacol, 2003, la8 (1) :91-98.
9Mela F, Marti M, Ulazzi L, et al. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5- hydroxytryptamine release in the mouse neocortex[J]. Eur J Neurosei, 2004,19 (5): 1317-1324.
